{"id":4892,"date":"2012-09-27T15:10:00","date_gmt":"2012-09-27T12:10:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/faktor-receteleri-hk\/"},"modified":"2026-01-19T11:09:47","modified_gmt":"2026-01-19T08:09:47","slug":"faktor-receteleri-hk","status":"publish","type":"post","link":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/","title":{"rendered":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK."},"content":{"rendered":"
\n
\n KAN \u00dcR\u00dcNLER\u0130 HK.\n<\/div>\n
\n  \n<\/div>\n
\n Sosyal G\u00fcvenlik kurumunun 28\/07\/2012 tarihinde yay\u0131nlam\u0131\u015f ve 05\/08\/2012 tarihinde y\u00fcr\u00fcrl\u00fc\u011fe giren SUT de\u011fi\u015fikli\u011finin, Fakt\u00f6r re\u00e7eteleri ile ilgili maddelerin, b\u00f6lgeler aras\u0131nda farkl\u0131 yorumlanmas\u0131 nedeniyle bir\u00e7ok ilde Eczac\u0131 meslekta\u015flar\u0131m\u0131z\u0131n faturalar\u0131ndan ciddi kesintiler olu\u015fmu\u015ftur.<\/b>\n<\/div>\n
\n \u015eanl\u0131urfa ili Sosyal G\u00fcvenlik kurumunda re\u00e7ete inceleme birimindeki Eczac\u0131 meslekta\u015flar\u0131m\u0131zla bug\u00fcn sabah konu ile ilgili olarak yapt\u0131\u011f\u0131m\u0131z g\u00f6r\u00fc\u015fmede, \u00fcyelerimizi ikinci bir duyuruya kadar 3 g\u00fcnl\u00fck tedavi dozunda kar\u015f\u0131lamalar\u0131 hususunda uyard\u0131\u011f\u0131m\u0131z\u0131 ve ma\u011fduriyet olu\u015fmamas\u0131 i\u00e7in bu tarihten \u00f6nceki re\u00e7etelerin kesintiye u\u011framamas\u0131 ve hatal\u0131 olarak kuruma teslim edilen raporlar\u0131n d\u00fczeltilmesi ile ilgili olarak talebimiz kurum taraf\u0131ndan kabul edilmi\u015f olup Eczac\u0131lar\u0131m\u0131z\u0131n ma\u011fduriyete u\u011framas\u0131 engellenmi\u015ftir. <\/b>\n<\/div>\n
\n  <\/b>\n<\/div>\n
\n Kan \u00dcr\u00fcn\u00fc Re\u00e7etelerini Kar\u015f\u0131larken :<\/b>\n<\/div>\n
\n 1*\u00d6ncelikle hastan\u0131n fakt\u00f6r d\u00fczeyine bak\u0131n\u0131z. Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda ise raporda \u201cproflaksi olarak tedavi almas\u0131 uygundur\u201d veya \u201cproflaksi endikasyon tedavisi alacakt\u0131r\u201d ifadesi tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi belirtilecektir. Bu bilgiler re\u00e7etede de yer alacakt\u0131r. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r.<\/b>\n<\/div>\n
\n 2*Fakt\u00f6r d\u00fczeyi %1 in \u00fczerinde ise raporda bu d\u00fczeyle birlikte \u201cayda \u00fc\u00e7ten fazla kanamas\u0131 olan ve proflaksi endikasyonu uygulamas\u0131 uygun g\u00f6r\u00fclm\u00fc\u015ft\u00fcr\u201d ifadesi raporda istenmektedir. Yine tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi istenmektedir. <\/b>\n<\/div>\n
\n Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r<\/b>\n<\/div>\n
\n 3*Akut kanamas\u0131 varsa 3 g\u00fcnl\u00fck dozdan fazla tedavi alamaz ve rapor S\u00fcresi 3 g\u00fcnl\u00fckt\u00fcr.. Raporda profilaksi endikasyonu veya ayda 3 ten fazla kanamas\u0131 oldu\u011fu belirtilmemi\u015f ise re\u00e7etede \u201csol diz hematroz- sa\u011f bilek hematroz veya burun kanamas\u0131-sol-sa\u011f-diz- bacak kanamas\u0131\u201d gibi te\u015fhislered 3 g\u00fcnl\u00fck tedavi dozunda kurum \u00f6deme yapacakt\u0131r. <\/b>\n<\/div>\n
\n 4*<\/b> Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.       <\/b>\n<\/div>\n
\n  <\/b>\n<\/div>\n
\n SUT 6.2.27.A Maddesi:<\/b>\n<\/div>\n
\n (1) Hastan\u0131n tan\u0131s\u0131, fakt\u00f6r d\u00fczeyi, varsa inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji uzman hekiminin olmad\u0131\u011f\u0131 hastanelerde ise \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan d\u00fczenlenecek sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji veya i\u00e7 hastal\u0131klar\u0131 veya \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan;           \n<\/div>\n
\n                  a) Akut kanamas\u0131 oldu\u011fu durumlarda ya da cerrahi giri\u015fimler \u00f6ncesi, rapor s\u00fcresi 3 g\u00fcn olmak \u00fczere,\n<\/div>\n
\n                  b) Fakt\u00f6r d\u00fczeyi % l’ in alt\u0131nda ve\/veya ayda \u00fc\u00e7ten fazla kanamas\u0131 olan hastalarda proflaksi endikasyonu konulduktan sonra haftal\u0131k fakt\u00f6r kullan\u0131m miktar\u0131 4500 \u00fcniteyi ge\u00e7medi\u011fi takdirde, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan verilen hastaya \u00f6zel Hemofili Takip Karnesine yaz\u0131larak verilecektir.        \n<\/div>\n
\n                (2) Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.      \n<\/div>\n
\n                (3) Acil m\u00fcracaatlarda; hastan\u0131n tam te\u015fekk\u00fcll\u00fc sa\u011fl\u0131k kurumlar\u0131na ba\u015fvurmas\u0131 halinde Hemofili Takip Karnesinin mevcut olmamas\u0131 veya bu belge mevcut, ancak ila\u00e7ta doz artt\u0131r\u0131lmas\u0131n\u0131 gerektirecek yeni bir endikasyonun geli\u015fmesi halinde ilk mesai g\u00fcn\u00fcnde raporun \u00e7\u0131kar\u0131lmas\u0131, re\u00e7ete veya tabela \u00fczerinde bu durumun hekimin el yaz\u0131s\u0131 ile belirtilmesi ko\u015fuluyla hastan\u0131n tedavisi sa\u011flanacakt\u0131r. Acil durumlarda hastaya en fazla bir g\u00fcnl\u00fck dozda ila\u00e7 yaz\u0131larak hematoloji uzman hekiminin bulundu\u011fu hastaneye sevk edilecektir.    \n<\/div>\n
\n             (4) Fakt\u00f6rVIIa, hastan\u0131n tan\u0131s\u0131n\u0131, fakt\u00f6r d\u00fczeyini (glanzmann trombastenisi hari\u00e7), inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak; klinik \u015fartlarda prospekt\u00fcs onayl\u0131 endikasyonlar\u0131nda hafif-orta \u015fiddetteki kanamalarda 3 doza kadar, merkezi sinir sistemi kanamalar\u0131nda veya hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda 12 doza kadar uzman hekim taraf\u0131ndan re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.\n<\/div>\n
\n            (5) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri; kazan\u0131lm\u0131\u015f koag\u00fclasyon bozukluklar\u0131 ve kazan\u0131lm\u0131\u015f hemofili hastalar\u0131nda; hafif-orta \u015fiddetteki kanamalarda, merkezi sinir sistemi kanamalar\u0131nda, hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda, klinik \u015fartlarda, bu durumun ve hastan\u0131n tan\u0131s\u0131 ile fakt\u00f6r d\u00fczeyini de (glanzmann trombastenisi ve inhibit\u00f6r geli\u015fmi\u015f hastalar hari\u00e7) belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak t\u00fcm uzman hekimler taraf\u0131ndan bir dozda re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.\n<\/div>\n
\n            (6) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri acil durumlarda;\n<\/div>\n
\n            a) Kumarin t\u00fcrevlerinin uygulanmas\u0131ndan kaynaklanan, aktif kanamas\u0131 olan hastalarda INR ve PT de\u011ferleri aranmaks\u0131z\u0131n kanama yeri belirtilmek ko\u015fulu ile uzman hekimlerce bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir. \u0130dame tedavi, prospekt\u00fcs\u00fcnde belirtilen doz \u015femas\u0131na uygun olarak yaln\u0131zca hematoloji uzman hekimlerince yap\u0131labilir.\n<\/div>\n
\n            b) Kumarin t\u00fcrevlerinin uygulanmas\u0131 s\u0131ras\u0131nda aktif kanamas\u0131 olmayan ancak kanama riski y\u00fcksek olan hastalarda ise INR de\u011ferine bak\u0131l\u0131r. INR de\u011feri\u22655 olan hastalarda hematoloji uzman hekimlerince, hematoloji uzman hekiminin bulunmad\u0131\u011f\u0131 illerde ise di\u011fer uzman hekimlerce en fazla bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir.\n<\/div>\n
\n                6.2.27.D- Hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu    \n<\/div>\n
\n               (1) Bu maddede yer alan fakt\u00f6rler ile di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesinde SUT’un fakt\u00f6r ve di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesi ve hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu maddesinde belirtilen ko\u015fullara da uyulacakt\u0131r.\n<\/div>\n
\n  \n<\/div>\n
\n  \n<\/div>\n
\n  \n<\/div>\n
\n SUT Komisyon Koordinat\u00f6r\u00fc: Ecz.Mehmet F\u0130TK\u0130\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

KAN \u00dcR\u00dcNLER\u0130 HK.   Sosyal G\u00fcvenlik kurumunun 28\/07\/2012 tarihinde yay\u0131nlam\u0131\u015f ve 05\/08\/2012 tarihinde y\u00fcr\u00fcrl\u00fc\u011fe giren SUT de\u011fi\u015fikli\u011finin, Fakt\u00f6r re\u00e7eteleri ile ilgili maddelerin, b\u00f6lgeler aras\u0131nda farkl\u0131 yorumlanmas\u0131 nedeniyle bir\u00e7ok ilde Eczac\u0131 meslekta\u015flar\u0131m\u0131z\u0131n faturalar\u0131ndan ciddi kesintiler olu\u015fmu\u015ftur. \u015eanl\u0131urfa ili Sosyal G\u00fcvenlik kurumunda re\u00e7ete inceleme birimindeki Eczac\u0131 meslekta\u015flar\u0131m\u0131zla bug\u00fcn sabah konu ile ilgili olarak yapt\u0131\u011f\u0131m\u0131z g\u00f6r\u00fc\u015fmede, \u00fcyelerimizi ikinci bir duyuruya kadar 3 g\u00fcnl\u00fck tedavi dozunda kar\u015f\u0131lamalar\u0131 hususunda uyard\u0131\u011f\u0131m\u0131z\u0131 ve ma\u011fduriyet olu\u015fmamas\u0131 i\u00e7in bu tarihten \u00f6nceki re\u00e7etelerin kesintiye u\u011framamas\u0131 ve hatal\u0131 olarak kuruma teslim edilen raporlar\u0131n d\u00fczeltilmesi ile ilgili olarak talebimiz kurum taraf\u0131ndan kabul edilmi\u015f olup Eczac\u0131lar\u0131m\u0131z\u0131n ma\u011fduriyete u\u011framas\u0131 engellenmi\u015ftir.   Kan \u00dcr\u00fcn\u00fc Re\u00e7etelerini Kar\u015f\u0131larken : 1*\u00d6ncelikle hastan\u0131n fakt\u00f6r d\u00fczeyine bak\u0131n\u0131z. Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda ise raporda \u201cproflaksi olarak tedavi almas\u0131 uygundur\u201d veya \u201cproflaksi endikasyon tedavisi alacakt\u0131r\u201d ifadesi tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi belirtilecektir. Bu bilgiler re\u00e7etede de yer alacakt\u0131r. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r. 2*Fakt\u00f6r d\u00fczeyi %1 in \u00fczerinde ise raporda bu d\u00fczeyle birlikte \u201cayda \u00fc\u00e7ten fazla kanamas\u0131 olan ve proflaksi endikasyonu uygulamas\u0131 uygun g\u00f6r\u00fclm\u00fc\u015ft\u00fcr\u201d ifadesi raporda istenmektedir. Yine tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi istenmektedir. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r 3*Akut kanamas\u0131 varsa 3 g\u00fcnl\u00fck dozdan fazla tedavi alamaz ve rapor S\u00fcresi 3 g\u00fcnl\u00fckt\u00fcr.. Raporda profilaksi endikasyonu veya ayda 3 ten fazla kanamas\u0131 oldu\u011fu belirtilmemi\u015f ise re\u00e7etede \u201csol diz hematroz- sa\u011f bilek hematroz veya burun kanamas\u0131-sol-sa\u011f-diz- bacak kanamas\u0131\u201d gibi te\u015fhislered 3 g\u00fcnl\u00fck tedavi dozunda kurum \u00f6deme yapacakt\u0131r. 4* Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.         SUT 6.2.27.A Maddesi: (1) Hastan\u0131n tan\u0131s\u0131, fakt\u00f6r d\u00fczeyi, varsa inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji uzman hekiminin olmad\u0131\u011f\u0131 hastanelerde ise \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan d\u00fczenlenecek sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji veya i\u00e7 hastal\u0131klar\u0131 veya \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan;                             a) Akut kanamas\u0131 oldu\u011fu durumlarda ya da cerrahi giri\u015fimler \u00f6ncesi, rapor s\u00fcresi 3 g\u00fcn olmak \u00fczere,                  b) Fakt\u00f6r d\u00fczeyi % l’ in alt\u0131nda ve\/veya ayda \u00fc\u00e7ten fazla kanamas\u0131 olan hastalarda proflaksi endikasyonu konulduktan sonra haftal\u0131k fakt\u00f6r kullan\u0131m miktar\u0131 4500 \u00fcniteyi ge\u00e7medi\u011fi takdirde, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan verilen hastaya \u00f6zel Hemofili Takip Karnesine yaz\u0131larak verilecektir.                        (2) Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.                      (3) Acil m\u00fcracaatlarda; hastan\u0131n tam te\u015fekk\u00fcll\u00fc sa\u011fl\u0131k kurumlar\u0131na ba\u015fvurmas\u0131 halinde Hemofili Takip Karnesinin mevcut olmamas\u0131 veya bu belge mevcut, ancak ila\u00e7ta doz artt\u0131r\u0131lmas\u0131n\u0131 gerektirecek yeni bir endikasyonun geli\u015fmesi halinde ilk mesai g\u00fcn\u00fcnde raporun \u00e7\u0131kar\u0131lmas\u0131, re\u00e7ete veya tabela \u00fczerinde bu durumun hekimin el yaz\u0131s\u0131 ile belirtilmesi ko\u015fuluyla hastan\u0131n tedavisi sa\u011flanacakt\u0131r. Acil durumlarda hastaya en fazla bir g\u00fcnl\u00fck dozda ila\u00e7 yaz\u0131larak hematoloji uzman hekiminin bulundu\u011fu hastaneye sevk edilecektir.                 (4) Fakt\u00f6rVIIa, hastan\u0131n tan\u0131s\u0131n\u0131, fakt\u00f6r d\u00fczeyini (glanzmann trombastenisi hari\u00e7), inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak; klinik \u015fartlarda prospekt\u00fcs onayl\u0131 endikasyonlar\u0131nda hafif-orta \u015fiddetteki kanamalarda 3 doza kadar, merkezi sinir sistemi kanamalar\u0131nda veya hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda 12 doza kadar uzman hekim taraf\u0131ndan re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (5) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri; kazan\u0131lm\u0131\u015f koag\u00fclasyon bozukluklar\u0131 ve kazan\u0131lm\u0131\u015f hemofili hastalar\u0131nda; hafif-orta \u015fiddetteki kanamalarda, merkezi sinir sistemi kanamalar\u0131nda, hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda, klinik \u015fartlarda, bu durumun ve hastan\u0131n tan\u0131s\u0131 ile fakt\u00f6r d\u00fczeyini de (glanzmann trombastenisi ve inhibit\u00f6r geli\u015fmi\u015f hastalar hari\u00e7) belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak t\u00fcm uzman hekimler taraf\u0131ndan bir dozda re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (6) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri acil durumlarda;            a) Kumarin t\u00fcrevlerinin uygulanmas\u0131ndan kaynaklanan, aktif kanamas\u0131 olan hastalarda INR ve PT de\u011ferleri aranmaks\u0131z\u0131n kanama yeri belirtilmek ko\u015fulu ile uzman hekimlerce bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir. \u0130dame tedavi, prospekt\u00fcs\u00fcnde belirtilen doz \u015femas\u0131na uygun olarak yaln\u0131zca hematoloji uzman hekimlerince yap\u0131labilir.            b) Kumarin t\u00fcrevlerinin uygulanmas\u0131 s\u0131ras\u0131nda aktif kanamas\u0131 olmayan ancak kanama riski y\u00fcksek olan hastalarda ise INR de\u011ferine bak\u0131l\u0131r. INR de\u011feri\u22655 olan hastalarda hematoloji uzman hekimlerince, hematoloji uzman hekiminin bulunmad\u0131\u011f\u0131 illerde ise di\u011fer uzman hekimlerce en fazla bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir.                6.2.27.D- Hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu                   (1) Bu maddede yer alan fakt\u00f6rler ile di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesinde SUT’un fakt\u00f6r ve di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesi ve hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu maddesinde belirtilen ko\u015fullara da uyulacakt\u0131r.       SUT Komisyon Koordinat\u00f6r\u00fc: Ecz.Mehmet F\u0130TK\u0130<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"\nFAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"KAN \u00dcR\u00dcNLER\u0130 HK.   Sosyal G\u00fcvenlik kurumunun 28\/07\/2012 tarihinde yay\u0131nlam\u0131\u015f ve 05\/08\/2012 tarihinde y\u00fcr\u00fcrl\u00fc\u011fe giren SUT de\u011fi\u015fikli\u011finin, Fakt\u00f6r re\u00e7eteleri ile ilgili maddelerin, b\u00f6lgeler aras\u0131nda farkl\u0131 yorumlanmas\u0131 nedeniyle bir\u00e7ok ilde Eczac\u0131 meslekta\u015flar\u0131m\u0131z\u0131n faturalar\u0131ndan ciddi kesintiler olu\u015fmu\u015ftur. \u015eanl\u0131urfa ili Sosyal G\u00fcvenlik kurumunda re\u00e7ete inceleme birimindeki Eczac\u0131 meslekta\u015flar\u0131m\u0131zla bug\u00fcn sabah konu ile ilgili olarak yapt\u0131\u011f\u0131m\u0131z g\u00f6r\u00fc\u015fmede, \u00fcyelerimizi ikinci bir duyuruya kadar 3 g\u00fcnl\u00fck tedavi dozunda kar\u015f\u0131lamalar\u0131 hususunda uyard\u0131\u011f\u0131m\u0131z\u0131 ve ma\u011fduriyet olu\u015fmamas\u0131 i\u00e7in bu tarihten \u00f6nceki re\u00e7etelerin kesintiye u\u011framamas\u0131 ve hatal\u0131 olarak kuruma teslim edilen raporlar\u0131n d\u00fczeltilmesi ile ilgili olarak talebimiz kurum taraf\u0131ndan kabul edilmi\u015f olup Eczac\u0131lar\u0131m\u0131z\u0131n ma\u011fduriyete u\u011framas\u0131 engellenmi\u015ftir.   Kan \u00dcr\u00fcn\u00fc Re\u00e7etelerini Kar\u015f\u0131larken : 1*\u00d6ncelikle hastan\u0131n fakt\u00f6r d\u00fczeyine bak\u0131n\u0131z. Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda ise raporda \u201cproflaksi olarak tedavi almas\u0131 uygundur\u201d veya \u201cproflaksi endikasyon tedavisi alacakt\u0131r\u201d ifadesi tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi belirtilecektir. Bu bilgiler re\u00e7etede de yer alacakt\u0131r. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r. 2*Fakt\u00f6r d\u00fczeyi %1 in \u00fczerinde ise raporda bu d\u00fczeyle birlikte \u201cayda \u00fc\u00e7ten fazla kanamas\u0131 olan ve proflaksi endikasyonu uygulamas\u0131 uygun g\u00f6r\u00fclm\u00fc\u015ft\u00fcr\u201d ifadesi raporda istenmektedir. Yine tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi istenmektedir. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r 3*Akut kanamas\u0131 varsa 3 g\u00fcnl\u00fck dozdan fazla tedavi alamaz ve rapor S\u00fcresi 3 g\u00fcnl\u00fckt\u00fcr.. Raporda profilaksi endikasyonu veya ayda 3 ten fazla kanamas\u0131 oldu\u011fu belirtilmemi\u015f ise re\u00e7etede \u201csol diz hematroz- sa\u011f bilek hematroz veya burun kanamas\u0131-sol-sa\u011f-diz- bacak kanamas\u0131\u201d gibi te\u015fhislered 3 g\u00fcnl\u00fck tedavi dozunda kurum \u00f6deme yapacakt\u0131r. 4* Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.         SUT 6.2.27.A Maddesi: (1) Hastan\u0131n tan\u0131s\u0131, fakt\u00f6r d\u00fczeyi, varsa inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji uzman hekiminin olmad\u0131\u011f\u0131 hastanelerde ise \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan d\u00fczenlenecek sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji veya i\u00e7 hastal\u0131klar\u0131 veya \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan;                             a) Akut kanamas\u0131 oldu\u011fu durumlarda ya da cerrahi giri\u015fimler \u00f6ncesi, rapor s\u00fcresi 3 g\u00fcn olmak \u00fczere,                  b) Fakt\u00f6r d\u00fczeyi % l’ in alt\u0131nda ve\/veya ayda \u00fc\u00e7ten fazla kanamas\u0131 olan hastalarda proflaksi endikasyonu konulduktan sonra haftal\u0131k fakt\u00f6r kullan\u0131m miktar\u0131 4500 \u00fcniteyi ge\u00e7medi\u011fi takdirde, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan verilen hastaya \u00f6zel Hemofili Takip Karnesine yaz\u0131larak verilecektir.                        (2) Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.                      (3) Acil m\u00fcracaatlarda; hastan\u0131n tam te\u015fekk\u00fcll\u00fc sa\u011fl\u0131k kurumlar\u0131na ba\u015fvurmas\u0131 halinde Hemofili Takip Karnesinin mevcut olmamas\u0131 veya bu belge mevcut, ancak ila\u00e7ta doz artt\u0131r\u0131lmas\u0131n\u0131 gerektirecek yeni bir endikasyonun geli\u015fmesi halinde ilk mesai g\u00fcn\u00fcnde raporun \u00e7\u0131kar\u0131lmas\u0131, re\u00e7ete veya tabela \u00fczerinde bu durumun hekimin el yaz\u0131s\u0131 ile belirtilmesi ko\u015fuluyla hastan\u0131n tedavisi sa\u011flanacakt\u0131r. Acil durumlarda hastaya en fazla bir g\u00fcnl\u00fck dozda ila\u00e7 yaz\u0131larak hematoloji uzman hekiminin bulundu\u011fu hastaneye sevk edilecektir.                 (4) Fakt\u00f6rVIIa, hastan\u0131n tan\u0131s\u0131n\u0131, fakt\u00f6r d\u00fczeyini (glanzmann trombastenisi hari\u00e7), inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak; klinik \u015fartlarda prospekt\u00fcs onayl\u0131 endikasyonlar\u0131nda hafif-orta \u015fiddetteki kanamalarda 3 doza kadar, merkezi sinir sistemi kanamalar\u0131nda veya hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda 12 doza kadar uzman hekim taraf\u0131ndan re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (5) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri; kazan\u0131lm\u0131\u015f koag\u00fclasyon bozukluklar\u0131 ve kazan\u0131lm\u0131\u015f hemofili hastalar\u0131nda; hafif-orta \u015fiddetteki kanamalarda, merkezi sinir sistemi kanamalar\u0131nda, hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda, klinik \u015fartlarda, bu durumun ve hastan\u0131n tan\u0131s\u0131 ile fakt\u00f6r d\u00fczeyini de (glanzmann trombastenisi ve inhibit\u00f6r geli\u015fmi\u015f hastalar hari\u00e7) belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak t\u00fcm uzman hekimler taraf\u0131ndan bir dozda re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (6) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri acil durumlarda;            a) Kumarin t\u00fcrevlerinin uygulanmas\u0131ndan kaynaklanan, aktif kanamas\u0131 olan hastalarda INR ve PT de\u011ferleri aranmaks\u0131z\u0131n kanama yeri belirtilmek ko\u015fulu ile uzman hekimlerce bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir. \u0130dame tedavi, prospekt\u00fcs\u00fcnde belirtilen doz \u015femas\u0131na uygun olarak yaln\u0131zca hematoloji uzman hekimlerince yap\u0131labilir.            b) Kumarin t\u00fcrevlerinin uygulanmas\u0131 s\u0131ras\u0131nda aktif kanamas\u0131 olmayan ancak kanama riski y\u00fcksek olan hastalarda ise INR de\u011ferine bak\u0131l\u0131r. INR de\u011feri\u22655 olan hastalarda hematoloji uzman hekimlerince, hematoloji uzman hekiminin bulunmad\u0131\u011f\u0131 illerde ise di\u011fer uzman hekimlerce en fazla bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir.                6.2.27.D- Hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu                   (1) Bu maddede yer alan fakt\u00f6rler ile di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesinde SUT’un fakt\u00f6r ve di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesi ve hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu maddesinde belirtilen ko\u015fullara da uyulacakt\u0131r.       SUT Komisyon Koordinat\u00f6r\u00fc: Ecz.Mehmet F\u0130TK\u0130\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2012-09-27T12:10:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:09:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"FAKT\u00d6R RE\u00c7ETELER\u0130 HK.\",\"datePublished\":\"2012-09-27T12:10:00+00:00\",\"dateModified\":\"2026-01-19T08:09:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/\"},\"wordCount\":1163,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/\",\"name\":\"FAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2012-09-27T12:10:00+00:00\",\"dateModified\":\"2026-01-19T08:09:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/2012\\\/09\\\/27\\\/faktor-receteleri-hk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FAKT\u00d6R RE\u00c7ETELER\u0130 HK.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#website\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/urfaeo.kolaysoft.com.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/","og_locale":"tr_TR","og_type":"article","og_title":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"KAN \u00dcR\u00dcNLER\u0130 HK.   Sosyal G\u00fcvenlik kurumunun 28\/07\/2012 tarihinde yay\u0131nlam\u0131\u015f ve 05\/08\/2012 tarihinde y\u00fcr\u00fcrl\u00fc\u011fe giren SUT de\u011fi\u015fikli\u011finin, Fakt\u00f6r re\u00e7eteleri ile ilgili maddelerin, b\u00f6lgeler aras\u0131nda farkl\u0131 yorumlanmas\u0131 nedeniyle bir\u00e7ok ilde Eczac\u0131 meslekta\u015flar\u0131m\u0131z\u0131n faturalar\u0131ndan ciddi kesintiler olu\u015fmu\u015ftur. \u015eanl\u0131urfa ili Sosyal G\u00fcvenlik kurumunda re\u00e7ete inceleme birimindeki Eczac\u0131 meslekta\u015flar\u0131m\u0131zla bug\u00fcn sabah konu ile ilgili olarak yapt\u0131\u011f\u0131m\u0131z g\u00f6r\u00fc\u015fmede, \u00fcyelerimizi ikinci bir duyuruya kadar 3 g\u00fcnl\u00fck tedavi dozunda kar\u015f\u0131lamalar\u0131 hususunda uyard\u0131\u011f\u0131m\u0131z\u0131 ve ma\u011fduriyet olu\u015fmamas\u0131 i\u00e7in bu tarihten \u00f6nceki re\u00e7etelerin kesintiye u\u011framamas\u0131 ve hatal\u0131 olarak kuruma teslim edilen raporlar\u0131n d\u00fczeltilmesi ile ilgili olarak talebimiz kurum taraf\u0131ndan kabul edilmi\u015f olup Eczac\u0131lar\u0131m\u0131z\u0131n ma\u011fduriyete u\u011framas\u0131 engellenmi\u015ftir.   Kan \u00dcr\u00fcn\u00fc Re\u00e7etelerini Kar\u015f\u0131larken : 1*\u00d6ncelikle hastan\u0131n fakt\u00f6r d\u00fczeyine bak\u0131n\u0131z. Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda ise raporda \u201cproflaksi olarak tedavi almas\u0131 uygundur\u201d veya \u201cproflaksi endikasyon tedavisi alacakt\u0131r\u201d ifadesi tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi belirtilecektir. Bu bilgiler re\u00e7etede de yer alacakt\u0131r. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r. 2*Fakt\u00f6r d\u00fczeyi %1 in \u00fczerinde ise raporda bu d\u00fczeyle birlikte \u201cayda \u00fc\u00e7ten fazla kanamas\u0131 olan ve proflaksi endikasyonu uygulamas\u0131 uygun g\u00f6r\u00fclm\u00fc\u015ft\u00fcr\u201d ifadesi raporda istenmektedir. Yine tan\u0131 ve varsa inhibit\u00f6r d\u00fczeyi istenmektedir. Re\u00e7etedeki Te\u015fhis k\u0131sm\u0131na : profilaktik tedavi+ tan\u0131 yaz\u0131lacakt\u0131r 3*Akut kanamas\u0131 varsa 3 g\u00fcnl\u00fck dozdan fazla tedavi alamaz ve rapor S\u00fcresi 3 g\u00fcnl\u00fckt\u00fcr.. Raporda profilaksi endikasyonu veya ayda 3 ten fazla kanamas\u0131 oldu\u011fu belirtilmemi\u015f ise re\u00e7etede \u201csol diz hematroz- sa\u011f bilek hematroz veya burun kanamas\u0131-sol-sa\u011f-diz- bacak kanamas\u0131\u201d gibi te\u015fhislered 3 g\u00fcnl\u00fck tedavi dozunda kurum \u00f6deme yapacakt\u0131r. 4* Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.         SUT 6.2.27.A Maddesi: (1) Hastan\u0131n tan\u0131s\u0131, fakt\u00f6r d\u00fczeyi, varsa inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji uzman hekiminin olmad\u0131\u011f\u0131 hastanelerde ise \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan d\u00fczenlenecek sa\u011fl\u0131k kurulu raporuna dayan\u0131larak, hematoloji veya i\u00e7 hastal\u0131klar\u0131 veya \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan;                             a) Akut kanamas\u0131 oldu\u011fu durumlarda ya da cerrahi giri\u015fimler \u00f6ncesi, rapor s\u00fcresi 3 g\u00fcn olmak \u00fczere,                  b) Fakt\u00f6r d\u00fczeyi % l’ in alt\u0131nda ve\/veya ayda \u00fc\u00e7ten fazla kanamas\u0131 olan hastalarda proflaksi endikasyonu konulduktan sonra haftal\u0131k fakt\u00f6r kullan\u0131m miktar\u0131 4500 \u00fcniteyi ge\u00e7medi\u011fi takdirde, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan verilen hastaya \u00f6zel Hemofili Takip Karnesine yaz\u0131larak verilecektir.                        (2) Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.                      (3) Acil m\u00fcracaatlarda; hastan\u0131n tam te\u015fekk\u00fcll\u00fc sa\u011fl\u0131k kurumlar\u0131na ba\u015fvurmas\u0131 halinde Hemofili Takip Karnesinin mevcut olmamas\u0131 veya bu belge mevcut, ancak ila\u00e7ta doz artt\u0131r\u0131lmas\u0131n\u0131 gerektirecek yeni bir endikasyonun geli\u015fmesi halinde ilk mesai g\u00fcn\u00fcnde raporun \u00e7\u0131kar\u0131lmas\u0131, re\u00e7ete veya tabela \u00fczerinde bu durumun hekimin el yaz\u0131s\u0131 ile belirtilmesi ko\u015fuluyla hastan\u0131n tedavisi sa\u011flanacakt\u0131r. Acil durumlarda hastaya en fazla bir g\u00fcnl\u00fck dozda ila\u00e7 yaz\u0131larak hematoloji uzman hekiminin bulundu\u011fu hastaneye sevk edilecektir.                 (4) Fakt\u00f6rVIIa, hastan\u0131n tan\u0131s\u0131n\u0131, fakt\u00f6r d\u00fczeyini (glanzmann trombastenisi hari\u00e7), inhibit\u00f6r d\u00fczeyini belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak; klinik \u015fartlarda prospekt\u00fcs onayl\u0131 endikasyonlar\u0131nda hafif-orta \u015fiddetteki kanamalarda 3 doza kadar, merkezi sinir sistemi kanamalar\u0131nda veya hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda 12 doza kadar uzman hekim taraf\u0131ndan re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (5) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri; kazan\u0131lm\u0131\u015f koag\u00fclasyon bozukluklar\u0131 ve kazan\u0131lm\u0131\u015f hemofili hastalar\u0131nda; hafif-orta \u015fiddetteki kanamalarda, merkezi sinir sistemi kanamalar\u0131nda, hayat\u0131 tehdit eden (hemodinami\u011fi bozan) \u015fiddetli kanamalarda veya cerrahi operasyonlarda, klinik \u015fartlarda, bu durumun ve hastan\u0131n tan\u0131s\u0131 ile fakt\u00f6r d\u00fczeyini de (glanzmann trombastenisi ve inhibit\u00f6r geli\u015fmi\u015f hastalar hari\u00e7) belirten hematoloji uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna dayan\u0131larak t\u00fcm uzman hekimler taraf\u0131ndan bir dozda re\u00e7ete edilebilir. Re\u00e7ete edilen \u00fcnitenin ka\u00e7 dozluk oldu\u011fu hekim taraf\u0131ndan re\u00e7ete \u00fczerinde belirtilir.            (6) Kombine koag\u00fclasyon fakt\u00f6r\u00fc\/Protrombin kompleksi konsantreleri acil durumlarda;            a) Kumarin t\u00fcrevlerinin uygulanmas\u0131ndan kaynaklanan, aktif kanamas\u0131 olan hastalarda INR ve PT de\u011ferleri aranmaks\u0131z\u0131n kanama yeri belirtilmek ko\u015fulu ile uzman hekimlerce bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir. \u0130dame tedavi, prospekt\u00fcs\u00fcnde belirtilen doz \u015femas\u0131na uygun olarak yaln\u0131zca hematoloji uzman hekimlerince yap\u0131labilir.            b) Kumarin t\u00fcrevlerinin uygulanmas\u0131 s\u0131ras\u0131nda aktif kanamas\u0131 olmayan ancak kanama riski y\u00fcksek olan hastalarda ise INR de\u011ferine bak\u0131l\u0131r. INR de\u011feri\u22655 olan hastalarda hematoloji uzman hekimlerince, hematoloji uzman hekiminin bulunmad\u0131\u011f\u0131 illerde ise di\u011fer uzman hekimlerce en fazla bir g\u00fcnl\u00fck dozda re\u00e7ete edilebilir.                6.2.27.D- Hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu                   (1) Bu maddede yer alan fakt\u00f6rler ile di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesinde SUT’un fakt\u00f6r ve di\u011fer kan \u00fcr\u00fcnlerinin re\u00e7ete edilmesi ve hemofili hastalar\u0131n\u0131n bildirim zorunlulu\u011fu maddesinde belirtilen ko\u015fullara da uyulacakt\u0131r.       SUT Komisyon Koordinat\u00f6r\u00fc: Ecz.Mehmet F\u0130TK\u0130","og_url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2012-09-27T12:10:00+00:00","article_modified_time":"2026-01-19T08:09:47+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"6 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#article","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK.","datePublished":"2012-09-27T12:10:00+00:00","dateModified":"2026-01-19T08:09:47+00:00","mainEntityOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/"},"wordCount":1163,"commentCount":0,"publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/","name":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#primaryimage"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2012-09-27T12:10:00+00:00","dateModified":"2026-01-19T08:09:47+00:00","breadcrumb":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#primaryimage","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/2012\/09\/27\/faktor-receteleri-hk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/urfaeo.kolaysoft.com.tr\/"},{"@type":"ListItem","position":2,"name":"FAKT\u00d6R RE\u00c7ETELER\u0130 HK."}]},{"@type":"WebSite","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#website","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urfaeo.kolaysoft.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/urfaeo.kolaysoft.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/urfaeo.kolaysoft.com.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/urfaeo.kolaysoft.com.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=4892"}],"version-history":[{"count":0,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/4892\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=4892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=4892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urfaeo.kolaysoft.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=4892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}